Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,066 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022.
Stolz D, Matera MG, Rogliani P, van den Berge M, Papakonstantinou E, Gosens R, Singh D, Hanania N, Cazzola M, Maitland-van der Zee AH, Fregonese L, Mathioudakis AG, Vestbo J, Rukhadze M, Page CP. Stolz D, et al. Among authors: singh d. Breathe (Sheff). 2023 Jun;19(2):220267. doi: 10.1183/20734735.0267-2022. Epub 2023 Jun 13. Breathe (Sheff). 2023. PMID: 37377851 Free PMC article. Review.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. Among authors: singh d. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction.
Hanania NA, Castro M, Bateman E, Pavord ID, Papi A, FitzGerald JM, Maspero JF, Katelaris CH, Singh D, Daizadeh N, Altincatal A, Pandit-Abid N, Soler X, Siddiqui S, Laws E, Jacob-Nara JA, Rowe PJ, Lederer DJ, Hardin M, Deniz Y. Hanania NA, et al. Among authors: singh d. Ann Allergy Asthma Immunol. 2023 Feb;130(2):206-214.e2. doi: 10.1016/j.anai.2022.10.018. Epub 2022 Nov 2. Ann Allergy Asthma Immunol. 2023. PMID: 36332763 Free article. Clinical Trial.
Identification of diurnal rhythmic blood markers in bronchial asthma.
Krakowiak K, Maidstone RJ, Chakraborty A, Kendall AC, Nicolaou A, Downton P, Cristian AD, Singh D, Loudon ASI, Ray DW, Durrington HJ. Krakowiak K, et al. Among authors: singh d. ERJ Open Res. 2023 Jul 3;9(4):00161-2023. doi: 10.1183/23120541.00161-2023. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37404842 Free PMC article.
Striving for Stability in Patients with COPD: A New Way Forward?
Han MK, Vanfleteren LEGW, Kolterer S, Stacey R, Singh D. Han MK, et al. Among authors: singh d. Adv Ther. 2024 Nov;41(11):3977-3981. doi: 10.1007/s12325-024-02982-y. Epub 2024 Sep 9. Adv Ther. 2024. PMID: 39249592 Free PMC article.
Novel anti-inflammatory treatments for asthma.
Bhowmick B, Singh D. Bhowmick B, et al. Among authors: singh d. Expert Rev Respir Med. 2008 Oct;2(5):617-29. doi: 10.1586/17476348.2.5.617. Expert Rev Respir Med. 2008. PMID: 20477297
8,066 results